Biggest News Aggregation in the World
📰 Low Dose News

Low Dose News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Low Dose. Real-time updates on events, politics, business and more.

AACR 2024: PDC*line Pharma presents interim clinical results from last cohort of patients in phase I

Intermediary results of high dose PDC*lung01 combined with pembrolizumab show mild safety profile, immunological activity and promising tumor response in Non-Small Cell Lung Cancer patientsCombination of high dose PDC*lung01 with pembrolizumab in 19 evaluable patients resulted in objective response rate of 63.2% and...
Region Flamande United States Johan Vansteenkiste Eric Halioua American Association For Cancer Research Non Small Cell Lung Cancer

AACR 2024: PDC*line Pharma Presents Interim Clinical Results From Last Cohort of Patients in Phase I/II Trial with PDC*lung01 Cancer Vaccine

LIÈGE, Belgium & GRENOBLE, France, April 08, 2024--PDC*line Pharma, a clinical-stage biotech company developing a new class of potent and scalable active immunotherapies for cancers, today announces the interim results from the last cohort of patients in its phase I/II clinical trial (PDC-LUNG-101, NCT03970746) with PDC*lung01.
United States South Korea Region Flamande Johan Vansteenkiste Eric Halioua American Association For Cancer Research
Source: yahoo.com

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science